Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha

Virology Journal

Volumn 7, Issue , 2010, Pages

  Yang, Lingli ^a,d   Kiyohara, Tomoko ^a,b   Kanda, Tatsuo ^a   Imazeki, Fumio ^a   Fujiwara, Keiichi ^a   Gauss Müller, Verena ^c   Ishii, Koji ^b   Wakita, Takaji ^b   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF LÜBECK   (Germany)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMANTADINE; ANTIVIRUS AGENT;

ARTICLE; CERCOPITHECIDAE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENOTYPE; HEPATITIS A VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; REPLICON; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; CERCOPITHECUS; DRUG INTERACTION; EPITHELIUM CELL; LIVER CELL; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; PROTEIN SYNTHESIS; TUMOR CELL LINE; VIROLOGY;

CERCOPITHECUS AETHIOPS; HEPATITIS A VIRUS; RNA VIRUSES;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DRUG INTERACTIONS; EPITHELIAL CELLS; HEPATITIS A VIRUS; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; MICROBIAL SENSITIVITY TESTS; PROTEIN BIOSYNTHESIS; VIRUS REPLICATION;

EID: 77956476488     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-212     Document Type: Article

References (19)

1. Hepatitis A and E: update on prevention and epidemiology. D FitzSimons G Hendrickx A Vorsters PV Damme, Vaccine 2010 28 583 588 10.1016/j.vaccine.2009. 10.136 19925903
2. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells. T Kanda O Yokosuka F Imazeki K Fujiwara K Nagao H Saisho, Biochem Biophys Res Commun 2005 331 621 629 10.1016/j.bbrc.2005.03.212 15850805
3. Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. A Widell BG Hansson B Oberg E Nordenfelt, Antiviral Res 1986 6 103 112 10.1016/0166-3542(86)90030-6 3010855
4. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site. T Kanda B Zhang Y Kusov O Yokosuka V Gauss-Müller, Biochem Biophys Res Commun 2005 330 1217 1223 10.1016/j.bbrc.2005.03.105 15823573
5. Internal ribosomal entry-site activities of clinical isolates-derived hepatitis A virus and inhibitory effects of amantadine. T Kanda F Imazeki S Nakamoto K Okitsu O Yokosuka, Hepatol Res 2010 40 415 423 10.1111/j.1872-034X. 2010.00617.x 20561355
6. Inhibition of hepatitis A virus replication in vitro by antiviral compounds. JM Crance E Biziagos J Passagot H van Cuyck-Gandre R Deloince, J Med Virol 1990 31 155 160 10.1002/jmv.1890310214 2167349
7. Amantadine as a regulator of internal ribosome entry site. Y Chen S Zeng JTA Hsu J Horng H Yang S Shih Y Chu T Wu, Acta Pharmacol Sin 2008 29 1327 1333 10.1111/j.1745-7254.2008.00876.x 18954527
8. Synthesis of new acridines and hydrazones derived from cyclic b-diketone for cytotoxic and antiviral evaluation. OI El-Sabbagh HM Rady, Eur J Med Chem 2009 44 3680 3686 10.1016/j.ejmech.2009.04.001 19423201
9. Replication of a hepatitis A virus replicon detected by genetic recombination in vivo. V Gauss-Müller YY Kusov, J Gen Virol 2002 83 2183 2192 12185272
10. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein. T Kanda V Gauss-Müller S Cordes R Tamura K Okitsu S Wu S Nakamoto K Fujiwara F Imazeki O Yokosuka, J Viral Hepat 2010 17 618 623 19889140
11. Interference of hepatitis A virus replication by small interfering RNAs. T Kanda Y Kusov O Yokosuka V Gauss-Müller, Biochem Biophys Res Commun 2004 318 341 345 10.1016/j.bbrc.2004.03.194 15120607
12. Genetic relatedness of hepatitis A strains recovered from different geographical regions. BH Robertson RW Jansen B Khanna A Totsuka OV Nainan G Siegl A Widell HS Margolis S Isomura K Ito T Ishizu Y Moritsugu SM Lemon, J Gen Virol 1992 73 1365 1377 10.1099/0022-1317-73-6-1365 1318940
13. Hepatitis A vaccine development in JPN. A Totsuka Y Moritsugu, Viral Hepatitis and Liver Disease Tokyo: Springer-Verlag, Nishioka K, Suzuki H, Mishiro S, 1994 509 513
14. Characterization of anti-idotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus. T Kiyohara A Totsuka T Yoneyama K Ishii T Ito T Wakita, Arch Virol 2009 154 1263 1269 10.1007/s00705-009-0433-6 19578927
15. Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. T Kanda R Steele R Ray RB Ray, J Virol 2007 81 12375 12381 10.1128/JVI.01695-07 17804510
16. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. V Fensterl D Grotheer I Berk S Schlemminger A Vallbracht A Dotzauer, J Virol 2005 79 10968 10977 10.1128/JVI.79.17.10968- 10977.2005 16103148
17. Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. D Paulmann T Magulski R Schwarz L Heitmann B Flehming A Vallbracht A Dotzauer, J Gen Virol 2008 89 1593 1604 10.1099/vir.0.83521-0 18559929
18. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Y Yang Y Liang L Qu Z Chen M Yi K Li SM Lemon, Proc Natl Acad Sci USA 2007 104 7253 7258 10.1073/pnas.0611506104 17438296
19. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. SD Cady K Schmidt-Rohr J Wang CS Soto WF Degrado M Hong, Nature 2010 463 689 692 10.1038/nature08722 20130653